ArticleACS medicinal chemistry letters2025

Second-Generation Cap Analogue Prodrugs for Targeting Aberrant Eukaryotic Translation Initiation Factor 4E Activity in Cancer.

Emilio L Cárdenas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.